Results 21 to 30 of about 303,596 (194)

Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' orbitopathy [PDF]

, 2012
BACKGROUND: Optimal doses of i.v. glucocorticoids for Graves' orbitopathy (GO) are undefined. METHODS: We carried out a multicenter, randomized, double-blind trial to determine efficacy and safety of three doses of i.v. methylprednisolone in 159 patients
Bernard M, for the European Group on Graves' Orbitopathy, Soeters, M R, Daumerie, C., Currò N, Nardi, M, Mourits, M P, Salvi M, Stahl, M., Boboridis KG, Nardi, M., Bernard, M., Stahl, M, Daumerie C, Baldeschi, L., Azzolini, C, Wiersinga, W., Sassi, L, Boschi A, MARCOCCI, CLAUDIO, Currò, N, Wiersinga W, von Arx, G, Boschi, A., Bournaud C, Boboridis, K G, Veronesi, G., Stahl M, Bartalena L, BALDESCHI, LELIO, Veronesi, G, Baldeschi, L, Bournaud, C., Mourits, M. P., Krassas GE, Sassi, L., Salvi, M., Currò, N., Krassas G, Baldeschi L, Veronesi G, Boschi, Antonella, VERONESI, GIOVANNI, Marcocci, C, SASSI, LORENZA, Azzolini C, Azzolini, C., von Arx, G., Mourits MP, Nardi M, Wiersinga, W, AZZOLINI, CLAUDIO, NARDI, MARCO, Bernard, M, for the European Group on Graves Orbitopathy, Boboridis, K. G., von Arx G, European Group on Graves' Orbitopathy, Marcocci C, Krassas, G. E., Daumerie, Chantal, Wiersinga WM, Soeters, M. R., Marcocci, C., BARTALENA, LUIGI, Bournaud, C, Salvi, M, Soeters MR, Sassi L, Curr? N, Bartalena, L., Krassas, G E, Bartalena, L   +72 more
core   +1 more source

Is Graves’ disease a primary immunodeficiency? New immunological perspectives on an endocrine disease

BMC Medicine, 2017
Background Uncertainty about factors influencing the susceptibility and triggers for Graves’ disease persists, along with a wide variation in the response to anti-thyroid drugs, currently at approximately 50% of non-responders.
Tristan Struja, Alexander Kutz, Stefan Fischli, Christian Meier, Beat Mueller, Mike Recher, Philipp Schuetz   +6 more
doaj   +1 more source

Application of ultrasound in diagnosing and follow-up of endocrine orbitopathy

, 2010
Endocrine orbitopathy or ophthalmopathy is an organ-specific, genetically conditioned autoimmune disease, resulting from a thyroid disorder. It is the most common cause of unilateral and bilateral proptosis in adults.
Sonja Cekic, Gordana Stankovic-Babic
core   +1 more source

Selenium and the course of mild Graves' orbitopathy

, 2011
Background Oxygen free radicals and cytokines play a pathogenic role in Graves' orbitopathy. Methods We carried out a randomized, double-blind, placebo-controlled trial to determine the effect of selenium (an antioxidant agent) or pentoxifylline (an ...
Altea M. A., Prummel M. D., BENCIVELLI, VALTER, Mourits MP, Nardi M., Kahaly GJ, Boboridis K., Pitz S, Altea MA, NARDI, MARCO, Prummel M, Krassas G. E., Kahaly G. J., Stahl M., von Arx G., von Arx G, European Group on Graves' Orbitopathy, MARCOCCI, CLAUDIO, Wiersinga W, Boboridis K, Mpourits M. P., Pitz S., Bencivelli W., Baldeschi L., BARTALENA, LUIGI, BALDESCHI, LELIO, Bartalena L, Stahl M, Sivelli P., Krassas GE, Wiersinga W. for the European Group on Graves' Orbitopathy, Sivelli P, Marcocci C.   +32 more
core   +1 more source

Total versus near-total thyroidectomy in Graves’ disease and their outcome on postoperative transient hypoparathyroidism: study protocol for a randomized controlled trial?

Trials, 2012
Background Graves’ disease is an independent risk factor for transient postoperative hypoparathyroidism. Besides the disease itself, preparation techniques are influential.
Maschuw Katja, Schlosser Katja, Lubbe Dirk, Nies Christoph, Bartsch Detlef   +4 more
doaj   +1 more source

Endocrine orbitopathy (graves disease): Transpalpebral fat decompression in combination with 3-wall bony expansion

, 2010
Endocrine orbitopathy (EO) is a chronic, multisystem autoimmune disorder caused by lymphocyte infiltration, edema, and proliferation of endo-orbital connective tissue.
Franco F., Clauser L. C., Tieghi R., Consorti G.   +3 more
core   +1 more source

Relationship of body composition to endocrine orbitopathy [PDF]

, 2018
In the theoretical part I briefly introduce the reader to the current state of given topic and describe the function of thyroid gland, how much important it is for our organism and also the possible influence of nutrition on this organ. The next chapters
Nová, Veronika
core  

Executive Summary to EDC-2 : The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals

, 2015
This Executive Summary to the Endocrine Society's second Scientific Statement on environmental endocrine-disrupting chemicals (EDCs) provides a synthesis of the key points of the complete statement.
Prins, Gail S.,, Gore, Andrea C.,, Chappell, Vesna A.,, Nadal, A.,, Toppari, Jorma,, Fenton, Suzanne E.,, Zoeller, R. Thomas,, Flaws, Jodi Anne,   +7 more
core   +1 more source

Thyroid Associared Orbitopathy [PDF]

, 2015
Thyroid-Associated Orbitopathy (TAO) merupakan manifestasi ekstratiroid dari suatu penyakit inflamasi autoimun yang menyerang jaringan orbita dan periorbita.
Soebagjo, Hendrian Dwikoloso
core   +1 more source

Graves’ orbitopathy as a rare disease in Europe: a European Group on Graves’ Orbitopathy (EUGOGO) position statement

Orphanet Journal of Rare Diseases, 2017
Background Graves’ orbitopathy (GO) is an autoimmune condition, which is associated with poor clinical outcomes including impaired quality of life and socio-economic status.
P. Perros, L. Hegedüs, L. Bartalena, C. Marcocci, G. J. Kahaly, L. Baldeschi, M. Salvi, J. H. Lazarus, A. Eckstein, S. Pitz, K. Boboridis, P. Anagnostis, G. Ayvaz, A. Boschi, T. H. Brix, N. Currò, O. Konuk, M. Marinò, A. L. Mitchell, B. Stankovic, F. B. Törüner, G. von Arx, M. Zarković, W. M. Wiersinga   +23 more
doaj   +1 more source